TY - JOUR T1 - Seasonality and Progression of COVID-19 among Countries With or Without Lock-downs JF - medRxiv DO - 10.1101/2020.12.06.20244780 SP - 2020.12.06.20244780 AU - Jose-Luis Sagripanti Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/12/07/2020.12.06.20244780.abstract N2 - Early predictions by computer simulation of 7 billion infections and 40 million deaths by COVID-19 during 2020 alone if lock-downs and other confining measures were not enforced may have justified restrictive policies mandated by governments of 165 countries. The aim of the present study was to determine differences between the infection and death rate in countries that established early, nation-wide lock-downs versus countries that did not mandated any lock-downs to deal with the COVID-19 crisis.The analyzed epidemiological data indicates that lock-downs, and other confining measures had no effect on the chances of healthy individuals becoming infected with SARS-CoV-2 or dying.The highest incidence of COVID-19 infection progressed from countries in northern latitudes, where it was winter at the beginning of the pandemic, to countries in the southern hemisphere in July 21, 2020 were winter was starting. A considerable (4-fold) increase in COVID-19 infection rate is observed between fall and beginning of winter in countries in the southern hemisphere. This seasonal progression correlates with the variation in the germicidal solar flux received by these countries, suggesting that infectious virus in the environment plays a role in the evolution of COVID-19.In addition, hypotheses are presented that could explain the recurrent new spikes of COVID-19 as well as the mortality of SARS-Co V-2 observed in some developed countries higher than the mortality rate reported in several developing countries.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. The author (Dr. Jose-Luis Sagripanti) is not associated to any industrial or commercial enterprise. The author is not associated to any political party, serving during 30 years under various governments with different political orientations. No economical or political issues were considered during the study presented here and the findings should not be construed as supporting or criticizing any party or particular governmentAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Department of Defense, US Army. RETIREDAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe epidemiological data employed in this study is freely available from the sources listed in References. Most reprint of the listed References can be downloaded from the world wide web. Those articles not freely available can be requested from the author. ER -